{
    "body": "What is the main component of the Lewy bodies?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23300799", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23295909", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15541000", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20534649", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22923347", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11412709", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20846907", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16969096", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18991634", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23183883", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10327208", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21683963", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21937912", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23382946", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22843682", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15530662", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23562579", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23384565", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11085897", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16951579", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24597591"
    ], 
    "ideal_answer": [
        "Parkinson's disease (PD) is characterized by the progressive degeneration of substantia nigra pars compacta (SNpc) dopaminergic neurones and the formation of Lewy bodies (LB) in a proportion of the remaining neurones. Alpha-synuclein has been identified as the main component of the Lewy bodies.", 
        "The main component of Lewy bodies is alpha-synuclein.", 
        "Parkinson s disease (PD) is one of the most common neurodegenerative diseases. Majority of PD are sporadic, for which genetic causes remain largely unknown. Alpha-synuclein, the main component of Lewy bodies, plays a central role in the PD pathogenesis  "
    ], 
    "exact_answer": [
        "Alpha-synuclein"
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016631", 
        "http://www.disease-ontology.org/api/metadata/DOID:12217", 
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020961"
    ], 
    "type": "factoid", 
    "id": "550c3d45a103b78016000008", 
    "snippets": [
        {
            "offsetInBeginSection": 350, 
            "offsetInEndSection": 443, 
            "text": "\u03b1-syn is the main component of Lewy bodies in Parkinson's disease (PD) and Lewy body dementia", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23562579", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 252, 
            "text": "Parkinson's disease (PD) is one of the most common neurodegenerative diseases. Majority of PD are sporadic, for which genetic causes remain largely unknown. Alpha-synuclein, the main component of Lewy bodies, plays a central role in the PD pathogenesis", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23384565", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 365, 
            "text": "Parkinson's disease (PD) is characterized by the progressive degeneration of substantia nigra pars compacta (SNpc) dopaminergic neurones and the formation of Lewy bodies (LB) in a proportion of the remaining neurones. \u03b1-synuclein is the main component of LB, but the pathological mechanisms that lead to neurodegeneration associated with LB formation remain unclear", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23382946", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 122, 
            "text": "\u03b1-Synuclein is the main component of Lewy bodies, the intraneuronal inclusion bodies characteristic of Parkinson's disease", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23300799", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 409, 
            "text": "Parkinson's disease (PD) is the second most common neurodegenerative disease. The majority of PD cases are sporadic, for which genetic causes and underlying molecular mechanisms remain largely unclear. Autophagy, a highly conserved cellular process that governs the breakdown of long-lived proteins and organelles, has been involved in the degradation of \u03b1-synuclein (\u03b1-Syn), the main component of Lewy bodies", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23295909", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 431, 
            "offsetInEndSection": 483, 
            "text": "The main component of Lewy bodies is alpha-synuclein", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18991634", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 153, 
            "text": "Alpha-synuclein, a main component of Lewy bodies in synucleinopathies and senile plaques in Alzheimer disease, is centrally involved in neurodegeneration", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16951579", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 111, 
            "offsetInEndSection": 274, 
            "text": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15541000", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 117, 
            "text": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15530662", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 197, 
            "text": "The pre-synaptic protein alpha-synuclein is the main component of Lewy bodies and Lewy neurites, the defining neuropathological characteristics of Parkinson's disease and dementia with Lewy bodies.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20534649", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 458, 
            "offsetInEndSection": 730, 
            "text": "Specifically, identification of Lewy bodies in fetal mesencephalic neurons transplanted in patients with Parkinson's disease raised the hypothesis that \u03b1-synuclein, the main component of Lewy bodies, could be transmitted from the host brain to a graft of healthy neurons.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20846907", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 421, 
            "offsetInEndSection": 654, 
            "text": "LBD has neuropathological characteristics whereby numerous Lewy bodies are present in the central and sympathetic nervous systems, and it is a type of alpha-synucleinopathy because the main component of Lewy body is alpha-synuclein.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24597591", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 152, 
            "offsetInEndSection": 273, 
            "text": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16969096", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 428, 
            "offsetInEndSection": 482, 
            "text": "The main component of Lewy bodies is alpha-synuclein.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18991634", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 172, 
            "offsetInEndSection": 231, 
            "text": "The main component of Lewy bodies is alpha-synuclein (AS).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22923347", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 118, 
            "text": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15530662", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 154, 
            "text": "Alpha-synuclein, a main component of Lewy bodies in synucleinopathies and senile plaques in Alzheimer disease, is centrally involved in neurodegeneration.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16951579", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 122, 
            "text": "\ufffd-Synuclein is the main component of Lewy bodies, the intraneuronal inclusion bodies characteristic of Parkinsons disease.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23300799", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 640, 
            "offsetInEndSection": 834, 
            "text": "In the 1990s, \ufffd-synuclein was identified as the main constituent of the Lewy pathology, and its aggregation was shown to be central to PD, dementia with Lewy bodies, and multiple system atrophy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23183883", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 180, 
            "text": "Identification of protein interfaces between \ufffd-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22843682", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 141, 
            "text": "Fibrillar \ufffd-synuclein (\ufffd-Syn) is the principal component of Lewy bodies, which are evident in individuals affected by Parkinson disease (PD).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22843682", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 110, 
            "text": "\ufffd-Synuclein is a major component of Lewy bodies in Parkinson disease (PD) and dementia with Lewy bodies (DLB).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21937912", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 431, 
            "offsetInEndSection": 484, 
            "text": "The main component of Lewy bodies is alpha-synuclein.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18991634", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 154, 
            "offsetInEndSection": 274, 
            "text": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16969096", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 463, 
            "offsetInEndSection": 735, 
            "text": "Specifically, identification of Lewy bodies in fetal mesencephalic neurons transplanted in patients with Parkinson's disease raised the hypothesis that \u00ce\u00b1-synuclein, the main component of Lewy bodies, could be transmitted from the host brain to a graft of healthy neurons.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20846907", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 111, 
            "offsetInEndSection": 273, 
            "text": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15541000", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 221, 
            "offsetInEndSection": 410, 
            "text": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11412709", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 154, 
            "offsetInEndSection": 273, 
            "text": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16969096", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 174, 
            "offsetInEndSection": 231, 
            "text": "The main component of Lewy bodies is alpha-synuclein (AS)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22923347", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 462, 
            "offsetInEndSection": 732, 
            "text": "Specifically, identification of Lewy bodies in fetal mesencephalic neurons transplanted in patients with Parkinson's disease raised the hypothesis that \u03b1-synuclein, the main component of Lewy bodies, could be transmitted from the host brain to a graft of healthy neurons", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20846907", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 111, 
            "offsetInEndSection": 272, 
            "text": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15541000", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 134, 
            "text": "alpha-Synuclein and ubiquitin are two Lewy body protein components that may play antagonistic roles in the pathogenesis of Lewy bodies", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11085897", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 159, 
            "offsetInEndSection": 275, 
            "text": "Recently, the presynaptic protein alpha-synuclein was shown to be a major component of Lewy bodies and Lewy neurites", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10327208", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 169, 
            "offsetInEndSection": 287, 
            "text": "Alpha-synuclein (AS) is the main component of Lewy bodies and its aggregation is a key event in the pathogenesis of PD", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21683963", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 100, 
            "text": "The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with Lewy bodies.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18991634", 
            "endSection": "title"
        }
    ]
}